|
 |
|
| |
|
Newsletter Sponsor
|
|
3D Printing: Empowering Complex Formulations With Optimized Properties
Adare Pharma Solutions has partnered with Laxxon Medical to provide the pharmaceutical market with cGMP 3D printing capabilities. Utilizing Laxxon's Screen-Printed Innovative Drug (SPID®) technology, Adare and Laxxon can create complex 3D-printed oral dosage formulations with optimized properties, including freely customizable release profiles of one or more APIs, improved bioavailability, and tailored pharmacokinetics. Learn more at CPHI Milan: visit booth #5A33 to speak with an Adare 3D printing expert.
 |
 |
|
|
|
|
|
|
|
|
 |
Featured Partners |
 |
|
| |
|
|
|
|
 |
Featured Video |
 |
|
| |
|
|
|
A Solid Dosage Future
In the pharmaceutical manufacturing space, while biopharmaceuticals often dominate discussions, it's crucial to acknowledge the enduring significance of solid dosage products (e.g., tablets, capsules,...
read more » |
 |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
Events
|
|
|
| |
|
|
|
AAPS 2024 PharmSci 360
Salt Lake City, UT – 10/20/2024
AAPS PharmSci 360 delivers research from across the pharmaceutical continuum. Thousands of scientists from across the globe converge to discuss ...
event details » |
 |
|
|
|
|
 |
|
|